Narrow Results Clear All
- Communication Improvement 1
- Error Reporting and Analysis 2
- Quality Improvement Strategies
- Specialization of Care 1
- Technologic Approaches 1
Search results for "Specific to High-Risk Drugs"
Cases & Commentaries
- Web M&M
Nicole M. Acquisto, PharmD, and Daniel J. Cobaugh, PharmD; March 2019
Seen in the emergency department, a man with insulin-dependent diabetes mellitus had not taken insulin for 3 days. His blood glucose levels were in the 800s with an anion-gap acidosis and positive beta hydroxybutyrate. While awaiting an ICU bed for treatment of diabetic ketoacidosis, the patient received fluids, an insulin drip was started, and blood glucose levels were monitored hourly. When lab results showed he was improving, the team decided to convert his insulin drip to subcutaneous long-acting insulin. However, both the intern and the resident ordered 50 units of insulin, and the patient received both doses—causing his blood glucose level to dip into the 30s.
Journal Article > Commentary
Achieving the Institute of Medicine's 6 aims for quality in the midst of the opioid crisis: considerations for the emergency department.
Waszak DL, Fennimore LA. J Emerg Nurs. 2017;43:512-518.
Addressing the opioid epidemic will require a multidimensional approach to improvement. This commentary reviews the literature on use of the Institute of Medicine six-aim care improvement framework in pain management in the emergency department to identify how emergency room nurses can help reduce unintended consequences associated with prescription opioid use.
Journal Article > Study
Kaiser SV, Asteria-Penaloza R, Vittinghoff E, Rosenbluth G, Cabana MD, Bardach NS. Pediatrics. 2014;133:e1139-e1147.
Codeine is considered a high-risk medication in children due to variability in its metabolization. Despite recommendations against its use, this analysis of national data over a 10-year period found only a slight decrease in codeine prescriptions for children seen in the emergency department.
Journal Article > Study
Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Ann Emerg Med. 2005;45:197-206.
This project studied the epidemiologic viability of using an injury surveillance system to track outpatient adverse drug events (ADEs) treated in hospital emergency departments. The authors found that the system could play a useful role in helping to understand outpatient ADEs, identifying areas for research, and monitoring ADE prevention.